Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Greenhalf

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes MellitusClaire Jenkinson, Victoria L Elliott, Anthony Evans, et al.
Pancreas|December 2, 2014
Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenacJames A Nicholson, William Greenhalf, Richard Jackson, et al.
BMJ Open|March 19, 2021
Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocolWega Setiabudi, Daniel Hungerford, Krishanthi Subramaniam, et al.
International Journal of Cancer|March 18, 2025
Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer riskJiangchuan He, Bilal Alashkar Alhamwe, Sergio Sabroso, et al.
Mucosal Immunology|November 23, 2023
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodiesDana Costigan, Joe Fenn, Sandi Yen, et al.
Gastroenterology|September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in MicePouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
Oncology Reports|February 14, 2013
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortiumCosmeri Rizzato, Daniele Campa, Raffaele Pezzilli, et al.
Plos One|November 2, 2016
Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic PancreatitisKarianne Fjeld, Sebastian Beer, Marianne Johnstone, et al.
Journal of the National Cancer Institute|December 1, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancerDylan Williams, Chandni Patel, Kate Murray, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes MellitusClaire Jenkinson, Victoria L Elliott, Anthony Evans, et al.
Pancreas|December 2, 2014
Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenacJames A Nicholson, William Greenhalf, Richard Jackson, et al.
BMJ Open|March 19, 2021
Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocolWega Setiabudi, Daniel Hungerford, Krishanthi Subramaniam, et al.
International Journal of Cancer|March 18, 2025
Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer riskJiangchuan He, Bilal Alashkar Alhamwe, Sergio Sabroso, et al.
Mucosal Immunology|November 23, 2023
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodiesDana Costigan, Joe Fenn, Sandi Yen, et al.
Gastroenterology|September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in MicePouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
Oncology Reports|February 14, 2013
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortiumCosmeri Rizzato, Daniele Campa, Raffaele Pezzilli, et al.
Plos One|November 2, 2016
Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic PancreatitisKarianne Fjeld, Sebastian Beer, Marianne Johnstone, et al.
Journal of the National Cancer Institute|December 1, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancerDylan Williams, Chandni Patel, Kate Murray, et al.
Pageof 13